Latest news for GelStat (OTC:GSAC) Stock

GelStat Corp is a consumer healthcare company operating in the USA. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.

GelStat Corp

GelStat's unit acquires key intellectual assets from Duos Technologies

GelStat's unit acquires key intellectual property assets from Duos Technologies

DUOT

GSAC

Press Releases

GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group

News

Top Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI)

NMRD

ORHB

SASI

GelStat

<a href="https://www.globenewswire.com/Tracker?data=Qt_o9kffufL9OLsFFGWE_BkDC4EttnxHDjvSREdDqFA3lf-VefqpIoAVcxzykfQlKG2fi2cBaHtaoVX-MncwsOaps5qgyT8wb9D14CRmUOU=" target="_blank">GelStat Corporation</a>&nbsp;(&quot;GelStat&quot; or the &quot;Company&quot;) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GSAC#OTC">GSAC</a>), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security and clean energy industries, today announced that its&nbsp;<a href="https://www.globenewswire.com/Tracker?data=S1OopHxgED-xLJ2_tWVXE39T0Azebzn7L5-1fU6PfxEJH8GwQc3tL1p-NkyJV8CZR-tM9sSeOtLP8JveQQ8uTCvvzCUfUaDzYfj5YRvYdYiyXx24ataeNR0dLo4Ayv3WcEvJ4G_JHAPyFCYeyYHpE5lJbwugJ8sDc7arm_bIE1iey1ds7IPMkV96KQEGnfVOqoz8iVgidvK3E0ajnUyopoul4f5UeoKuVWjIHY0ICIM=" target="_blank">recently formed</a>&nbsp;subsidiary, GSAC Engineering (&quot;GSACe&quot;), has concluded the purchase of certain key intellectual property assets from Duos Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) (&quot;Duos&quot;).

Asset Sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

GelStat

News

Latest news for GelStat (OTC:GSAC) Stock

Tuesday, September 12, 2023